New Key Statistics Module, Z-Score and F-Score
SZSE:300357 Key Ratios
Market Cap ¥ M | 9,649.65 |
Enterprise Value ¥ M | 8,557.63 |
P/E(ttm) | 30.87 |
PE Ratio without NRI | 30.87 |
Forward PE Ratio | 23.24 |
Price/Book | 4.09 |
Price/Sales | 10.67 |
Price/Free Cash Flow | 58.32 |
Price/Owner Earnings | 48.37 |
Payout Ratio % | 0.31 |
Revenue (TTM) ¥ M | 904.00 |
EPS (TTM) ¥ | 0.60 |
Beneish M-Score | -2.41 |
10-y EBITDA Growth Rate % | 17.20 |
5-y EBITDA Growth Rate % | 9.10 |
y-y EBITDA Growth Rate % | 11.20 |
EV-to-EBIT | 23.82 |
EV-to-EBITDA | 23.82 |
PEG | 3.39 |
Shares Outstanding M | 523.58 |
Net Margin (%) | 34.52 |
Operating Margin % | 35.85 |
Pre-tax Margin (%) | 39.58 |
Quick Ratio | 9.77 |
Current Ratio | 10.09 |
ROA % (ttm) | 11.94 |
ROE % (ttm) | 13.94 |
ROIC % (ttm) | 22.31 |
Dividend Yield % | 1.55 |
Altman Z-Score | 27.17 |
SZSE:300357 Number of Guru Trades
SZSE:300357 Volume of Guru Trades
Gurus Latest Trades with SZSE:300357
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300357 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Insider Transactions
No Available Data